William Blair analyst Andy Hsieh downgraded Pyxis Oncology (PYXS) to Market Perform from Outperform. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on PYXS: Closing Bell Movers: Nvidia down slightly after Q3 results Pyxis Oncology Reports Promising Phase 1 Trial Results Pyxis Oncology announces preliminary PYX-201 data, collaboration with Merck Pyxis Oncology reports Q3 EPS (35c), consensus (31c) Pyxis Oncology sees cash runway into 2H26